{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:06:59Z","timestamp":1788923219570,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4977,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1016\/s1097-2765(00)80233-6","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T12:29:33Z","timestamp":1083673773000},"page":"1051-1061","source":"Crossref","is-referenced-by-count":192,"title":["Formation of the VHL\u2013Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiC"],"prefix":"10.1016","volume":"4","author":[{"given":"Douglas E","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanitha","family":"Thulasiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul G","family":"Ferreyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Frydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1097-2765(00)80233-6_BIB1","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.7660129","article-title":"Elongin (SIII)","volume":"269","author":"Aso","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)80928-9","article-title":"The Hsp70 and Hsp60 chaperone machines","volume":"92","author":"Bukau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"5","author":"Chen","year":"1995","journal-title":"Hum. Mutat."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB4","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1073\/pnas.92.14.6459","article-title":"Characterization of the VHL tumor suppressor gene product","volume":"92","author":"Duan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0959-440X(94)90069-8","article-title":"Roles of molecular chaperones in protein-folding","volume":"4","author":"Ellis","year":"1994","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0960-9822(99)80082-7","article-title":"Molecular chaperones","volume":"9","author":"Ellis","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.272.5267.1497","article-title":"Principles of chaperone-assisted protein folding","volume":"272","author":"Frydman","year":"1996","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0968-0004(97)01005-0","article-title":"Chaperones get in touch","volume":"22","author":"Frydman","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/370111a0","article-title":"Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones","volume":"370","author":"Frydman","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/emboj\/17.4.952","article-title":"A novel protein complex promoting formation of functional alpha- and gamma-tubulin","volume":"17","author":"Geissler","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB13","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","article-title":"Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene","volume":"93","author":"Gnarra","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/381571a0","article-title":"Molecular chaperones in cellular protein folding","volume":"381","author":"Hartl","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumour suppression by the human von Hippel-Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0092-8674(00)80327-X","article-title":"Protein folding in vivo","volume":"90","author":"Johnson","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/20309","article-title":"Cancer","volume":"399","author":"Kaelin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB18","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1101\/gad.12.24.3872","article-title":"The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families","volume":"12","author":"Kamura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)80753-9","article-title":"How the cyclin became a cyclin","volume":"97","author":"Koepp","year":"1999","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-1033.1995.tb20527.x","article-title":"The chaperonin containing T-complex polypeptide-1 (Tcp-1)","volume":"230","author":"Kubota","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB24","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1073\/pnas.93.5.1770","article-title":"Nuclear\/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density","volume":"93","author":"Lee","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/MCB.19.2.1486","article-title":"Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Lee","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.132.1.1","article-title":"Chaperonin-mediated folding of actin and tubulin","volume":"132","author":"Lewis","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jama.1995.03520310062031","article-title":"Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer","volume":"273","author":"Linehan","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB28","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1101\/gad.13.14.1822","article-title":"The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity","volume":"13","author":"Lisztwan","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","article-title":"Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B\/C and Cul2","volume":"18","author":"Lonergan","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1101\/gad.13.5.505","article-title":"A ubiquitin ligase complex essential for the NF-kappa B; Wnt\/Wingless; and Hedgehog signaling pathways","volume":"13","author":"Maniatis","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB33","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/pro.5560050715","article-title":"Novel isolation method and structural stability of a eukaryotic chaperonin","volume":"5","author":"Norcum","year":"1996","journal-title":"Protein Sci."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von-Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB35","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1073\/pnas.95.3.993","article-title":"The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal","volume":"95","author":"Pause","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB37","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.96.17.9533","article-title":"Studying interactions of four proteins in the yeast two-hybrid system","volume":"96","author":"Pause","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB38","first-page":"2852","article-title":"Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/emboj\/18.1.75","article-title":"Compartmentation of protein folding in vivo","volume":"18","author":"Siegers","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB40","first-page":"493","article-title":"Molecular chaperones","volume":"50","author":"Smith","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL\u2013ElonginC\u2013ElonginB complex","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80787-4","article-title":"Polypeptide flux through bacterial Hsp70","volume":"97","author":"Teter","year":"1999","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/emboj\/18.1.85","article-title":"In vivo newly translated polypeptides are sequestered in a protected folding environment","volume":"18","author":"Thulasiraman","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB44","first-page":"2881","article-title":"Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product","volume":"56","author":"Tsuchiya","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB45","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0092-8674(00)81446-4","article-title":"Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin","volume":"93","author":"Vainberg","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB46","first-page":"1092","article-title":"Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma","volume":"55","author":"Whaley","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<62::AID-IJC11>3.0.CO;2-7","article-title":"Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle\u2013dependent","volume":"78","author":"Ye","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1097-2765(00)80233-6_BIB48","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1101\/gad.13.16.2039","article-title":"Whose end is destruction","volume":"13","author":"Zachariae","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/S1097-2765(00)80233-6_BIB49","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","article-title":"The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276500802336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276500802336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T18:51:05Z","timestamp":1549738265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276500802336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S1097276500802336"],"URL":"https:\/\/doi.org\/10.1016\/s1097-2765(00)80233-6","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}